Madrigal Pharmaceuticals
MDGL
#2088
Rank
โ‚น816.08 B
Marketcap
โ‚น35,131
Share price
-4.45%
Change (1 day)
-28.54%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2026 (TTM): -โ‚น541.16

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น547.68. In 2025 the company made an earnings per share (EPS) of -โ‚น990.64 an increase over its 2024 EPS that were of -โ‚น2,049.

EPS history for Madrigal Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น541.16-45.37%
2025-โ‚น990.64-51.65%
2024-โ‚น2,049
2022-โ‚น1,59717.93%
2021-โ‚น1,35411.61%
2020-โ‚น1,213140.18%
2019-โ‚น505.05146.61%
2018-โ‚น204.80-12.99%
2017-โ‚น235.38-91.03%
2016-โ‚น2,623

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น17.61-96.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น88.04-83.93%๐Ÿ‡บ๐Ÿ‡ธ USA